 Connection
Mark Abzug to Anti-HIV Agents
This is a "connection" page, showing publications Mark Abzug has written about Anti-HIV Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.390 |
|
|
|
-
Weinberg A, Giganti MJ, Sirois PA, Montepiedra G, Canniff J, Agwu A, Boivin MJ, Kapetanovic S, Abzug MJ. Coordination of inflammatory responses in children with perinatally acquired HIV infection. AIDS. 2022 07 01; 36(8):1117-1127.
Score: 0.136
-
Melvin AJ, Montepiedra G, Aaron L, Meyer WA, Spiegel HM, Borkowsky W, Abzug MJ, Best BM, Crain MJ, Borum PR, Graham B, Anthony P, Shin K, Siberry GK. Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia. Pediatr Infect Dis J. 2017 01; 36(1):53-60.
Score: 0.094
-
Abzug MJ, Warshaw M, Rosenblatt HM, Levin MJ, Nachman SA, Pelton SI, Borkowsky W, Fenton T. Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis. 2009 Sep 15; 200(6):935-46.
Score: 0.057
-
Abzug MJ, Pelton SI. Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox. J Infect Dis. 2009 Apr 15; 199(8):1109-11.
Score: 0.055
-
Brogly SB, Ylitalo N, Mofenson LM, Oleske J, Van Dyke R, Crain MJ, Abzug MJ, Brady M, Jean-Philippe P, Hughes MD, Seage GR. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS. 2007 May 11; 21(8):929-38.
Score: 0.048
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|